Description

This Veterans Day, we’re shining a light on care for those who’ve served.

Dr. Elizabeth (Betsy) O’Donnell, Director of the Multi-Cancer Early Detection Clinic at Dana-Farber Cancer Institute, joins the PQI Podcast to discuss the Sentinel Study—a Department of Defense–sponsored clinical trial offering multi-cancer early detection (MCED) testing to U.S. veterans.

Through a single blood draw, the test can screen for more than 50 types of cancer, addressing the urgent need for improved screening among veterans, who face a cancer risk nearly 20% higher than the general population.

Dr. O’Donnell shares how this innovative study combines science, service, and compassion to bring life-saving research to those who’ve served—and what it could mean for the future of oncology care.

Listen to learn more about:

• How early detection technology is transforming the future of cancer care
• Why veterans face unique cancer risks linked to their service
• What makes the Sentinel Study a model for accessible, equitable screening
• The personal motivation that drives Dr. O’Donnell’s work

For more information on the Sentinel study or to determine eligibility, visit redcap.link/VeteransScreeningStudy or contact the Sentinel Team at dfciprevention@mgb.org